glp-1 agonist weight loss medications alternatives FDA approves Foundayo, an oral alternative to Wegovy and Ozempic GLP-1 Agonists Transform Diabetes &
Description
Hes also had a history of chronic lower gastrointestinal (GI) tract issues
Diabetes 59 , 30993107 (2010)

29:376-383 [PMC free article: PMC7614216] [PubMed: 36477733] 14

Interactive hemodynamic effects of dipeptidyl peptidase-IV inhibition and angiotensin-converting enzyme inhibition in humans

Less common side effects include acid reflux symptoms, injection site irritation, or changes in bowel habits
